Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Purpose To investigate whether the blood-brain barrier (BBB) leaks blood-circulating substances in patients with early forms of Alzheimer disease (AD), and if so, to examine the extent and pattern of leakage. Materials and Methods This study was approved by the local medical ethical committees of the Maastricht University Medical Center and Leiden University Medical Center, and written informed consent was obtained from all subjects. For this pilot study, 16 patients with early AD and 17 healthy age-matched control subjects underwent dynamic contrast material–enhanced magnetic resonance (MR) imaging sequence with dual time resolution for 25 minutes. The Patlak graphical approach was used to quantify the BBB leakage rate and local blood plasma volume. Subsequent histogram analysis was used to determine the volume fraction of the leaking brain tissue. Differences were assessed with linear regression analysis, adjusted for confounding variables. Results The BBB leakage rate was significantly higher in patients compared with that in control subjects in the total gray matter (P < .05) and cortex (P = .03). Patients had a significantly higher volume fraction of the leaking brain tissue in the gray matter (P = .004), normal-appearing white matter (P < .04), deep gray matter (P = .01), and cortex (P = .004). When all subjects were considered, scores on the Mini-Mental State Examination decreased significantly with increasing leakage in the deep gray matter (P = .007) and cortex (P < .05). Conclusion The results of this study showed global BBB leakage in patients with early AD that is associated with cognitive decline. A compromised BBB may be part of a cascade of pathologic events that eventually lead to cognitive decline and dementia. ©RSNA, 2016 Online supplemental material is available for this article. An earlier incorrect version of this article appeared online. This article was corrected on October 24, 2016.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent neuroimaging studies in individuals with mild cognitive impairment (MCI) and early AD reveal BBB breakdown in the hippocampus, including its CA1 and dentate gyrus subfields (421), and several gray and white matter regions (220-222), respectively, before brain atrophy and dementia.”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [220]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“BBB leakiness is seen both with normal ageing and AD [124,125].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [125]
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, the BBB disruption and increased permeability have been shown to occur in the early phase of the AD pathology (van de Haar et al., 2016).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as van de Haar et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,567
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
Research works printed but not linked: 1
- Butman J, 2006, Proceedings of the Fourteenth Meeting of the International Society for Magnetic Resonance in Medicine, 1535
Cited by
Items 301–400 of 653
Ritson, M., Wheeler-Jones, C. P. D., & Stolp, H. B. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578363 · Cited by 26
DNA methylation patterns of LINE-1 and Alu for pre-symptomatic dementia in type 2 diabetes
Sae-Lee, C., Biasi, J. D., Robinson, N., Barrow, T. M., Mathers, J. C., Koutsidis, G., & Byun, H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234578 · Cited by 26
“In the case of dementia, there is evidence that epigenetic marks in blood can serve as biomarkers of early disease, which may be related to brain-blood barrier leakage in the early stages of Alzheimer disease [54].”
BackgroundDiabetic retinopathy and dementia association, beyond diabetes severity
Lee, C. S., Krakauer, C., Su, Y.-R., Walker, R. L., Blazes, M., McCurry, S. M., Bowen, J. D., McCormick, W. C., Lee, A. Y., Boyko, E. J., et al. (2023) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2022.12.003 · Cited by 25
Kovbasyuk, Z., Tefera, E., Li, C., Baete, S. H., & Steriade, C. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03598-x · Cited by 25
Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease
Nelson, A. R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.858429 · Cited by 25
López-Ornelas, A., Jiménez, A., Pérez‐Sánchez, G., Rodríguez-Pérez, C. E., Corzo‐Cruz, A., Velasco, I., & Estudillo, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710136 · Cited by 25
Prospective T1 mapping to assess gadolinium retention in brain after intrathecal gadobutrol
Ringstad, G. A., Valnes, L. M., Vatnehol, S. A. S., Pripp, A. H., & Eide, P. K. (2023) · Neuroradiology · doi:10.1007/s00234-023-03198-7 · Cited by 25
Association of Plasma Claudin-5 with Age and Alzheimer Disease
Tachibana, K., Hirayama, R., Sato, N., Hattori, K., Kato, T., Takeda, H., & Kondoh, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031419 · Cited by 25
Dumitrascu, O. M., Doustar, J., Fuchs, D.-T. S., Koronyo, Y., Sherman, D. S., Miller, M. S., Johnson, K., Carare, R. O., Verdooner, S. R., Lyden, P. D., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01810-2 · Cited by 25
Fibrin-targeting immunotherapy for dementia
Kantor, A. B., Akassoglou, K., & Stavenhagen, J. B. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2023.105 · Cited by 24
Nwafor, D. C., Brichacek, A. L., Ali, A., & Brown, C. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105257 · Cited by 24
Filippopulos, F. M., Fischer, T. D., Seelos, K., Dunker, K., Belanovic, B., Crispin, A., Stahl, R., Liebig, T., Straube, A. M., & Forbrig, R. (2022) · Investigative Radiology · doi:10.1097/rli.0000000000000870 · Cited by 24
Naganawa, S., Ito, R., Kato, Y., Kawai, H., Taoka, T., Yoshida, T., Maruyama, K., Murata, K., Koerzdoerfer, G., Pfeuffer, J., et al. (2020) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.mp.2020-0030 · Cited by 24
Naganawa, S., Ito, R., Nakamichi, R., Kawamura, M., Kawai, H., Taoka, T., Yoshida, T., & Sone, M. (2020) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.mp.2020-0062 · Cited by 24
Bernal, J., Hernández, M. V., Escudero, J., Heye, A. K., Sakka, E., Armitage, P. A., Makin, S., Touyz, R. M., Wardlaw, J. M., & Thrippleton, M. J. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.117786 · Cited by 24
An, Y., Qi, Y. A., Li, Y., Li, Z., Yang, C., & Dong, J. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136528 · Cited by 24
Gut Microbiota as a Hidden Player in the Pathogenesis of Alzheimer’s Disease
Choi, H., Lee, D., & Mook‐Jung, I. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215235 · Cited by 24
Role of the gut microbiome in Alzheimer’s disease
Chok, K. C., Ng, K. Y., Koh, R. Y., & Chye, S. M. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0122 · Cited by 23
Effects of cerebral amyloid angiopathy on the brain vasculome
Deng, W., Guo, S., van Veluw, S. J., Yu, Z., Chan, S. J., Takase, H., Arai, K., Ning, M., Greenberg, S. M., Lo, E. H., et al. (2022) · Aging Cell · doi:10.1111/acel.13503 · Cited by 23
“…D S aging, brain vasculome, cerebral amyloid angiopathy, cerebral endothelial transcriptome observed with various vascular lesions such as blood– brain barrier (BBB) leakage, cerebral microbleeds, and multiple microinfarcts (Montagne et al., 2016; Poliakova et al., 2016; van de Haar et al., 2016).”
BackgroundVascular endothelial cells: a fundamental approach for brain waste clearance
Wei, H., Jiang, H., Zhou, Y., Xiao, X., Zhou, C., & Ji, X. (2022) · Brain · doi:10.1093/brain/awac495 · Cited by 23
Hnilicová, P., Kantorová, E., Šutovský, S., Grofik, M., Zeleňák, K., Kurča, E., Žilka, N., Parvanovova, P., & Kolísek, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043325 · Cited by 23
Powell, E., Ohene, Y., Battiston, M., Dickie, B., Parkes, L. M., & Parker, G. J. M. (2023) · Magnetic Resonance in Medicine · doi:10.1002/mrm.29616 · Cited by 23
Zailani, H., Satyanarayanan, S. K., Liao, W.-C., Hsu, Y., Huang, S., Gałecki, P., Su, K., & Chang, J. P. (2023) · Nutrients · doi:10.3390/nu15204363 · Cited by 23
Denkinger, M. N., Baker, S. L., Inglis, B. A., Kobayashi, S., Juarez, A., Mason, S., & Jagust, W. J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299764 · Cited by 23
Zedde, M., & Pascarella, R. (2024) · Brain Sciences · doi:10.3390/brainsci14100983 · Cited by 23
Effect of Obesity on Cognitive Impairment in Vascular Dementia Rat Model via BDNF-ERK-CREB Pathway
Kim, Y., & Kim, Y. (2020) · Biological Research For Nursing · doi:10.1177/1099800420951633 · Cited by 23
A Perspective on Roles Played by Immunosenescence in the Pathobiology of Alzheimer's Disease
Zhao, Y. G., Zhan, J., & Liu, Y. (2020) · Aging and Disease · doi:10.14336/ad.2020.0205 · Cited by 23
Erythrocytes, a New Contributor to Age‐Associated Loss of Blood–Brain Barrier Integrity
Amiri, P., DeCastro, J., Littig, J., Lu, H., Liu, C., Conboy, I. M., & Aran, K. (2021) · Advanced Science · doi:10.1002/advs.202101912 · Cited by 23
Quantitative Imaging of Blood-Brain Barrier Permeability Following Repetitive Mild Head Impacts
Leaston, J., Qiao, J., Harding, I. C., Kulkarni, P., Gharagouzloo, C. A., Ebong, E. E., & Ferris, C. F. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.729464 · Cited by 22
“Given the reports that BBB leakagemay play a critical role in the pathophysiology of early AD (76) and cerebral amyloid angiopathy (77) QUTE-CE may provide a sensitive method for early diagnosis and assement of treatment efficacy.”
MethodChaudhuri, S., Cho, M., Stumpff, J., Bice, P. J., İş, Ö., Ertekin‐Taner, N., Saykin, A. J., & Nho, K. T. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00798-0 · Cited by 22
McInerney, M. P., Short, J. L., & Nicolazzo, J. A. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0077-5 · Cited by 22
Saiyasit, N., Butlig, E.-A. R., Chaney, S. D., Traylor, M. K., Hawley, N. A., Randall, R. B., Bobinger, H. V., Frizell, C. A., Trimm, F., Crook, E. D., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.915405 · Cited by 22
Barré, F. P. Y., Heeren, R. M. A., & Ogrinc, N. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170111112550 · Cited by 22
Restoring brain barriers: an innovative approach for treating neurological disorders
Lemarchant, S., Engelhardt, B., Cicchetti, F., Bix, G. J., Janus, A., Godfrin, Y., Blasco, H., Campbell, M., & Jacquet, A. D. R. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00688-z · Cited by 21
Ohene, Y., Harris, W. J., Powell, E., Wycech, N. W., Smethers, K. F., Lasič, S., South, K., Coutts, G., Sharp, J., Lawrence, C. B., et al. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00422-7 · Cited by 21
Contrast leakage distant from the hematoma in patients with spontaneous ICH: A 7 T MRI study
Jolink, W. M. T., Lindenholz, A., van Etten, E. S., van Nieuwenhuizen, K. M., Schreuder, F. H. B. M., Kuijf, H. J., van Osch, M. J. P., Hendrikse, J., Rinkel, G. J. E., Wermer, M. J. H., et al. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19852876 · Cited by 21
Protective Effects of Complement Component 8 Gamma Against Blood-Brain Barrier Breakdown
Kim, J., Han, J., & Suk, K. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.671250 · Cited by 21
Gaire, B. P., Koronyo, Y., Vit, J., Hutton, A., Subedi, L., Fuchs, D.-T. S., Swerdlow, N., Rentsendorj, A., Shahin, S., Martinon, D., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68580-4 · Cited by 20
Blood–brain barrier permeability in Parkinson’s disease patients with and without dyskinesia
Fujita, K., Peng, S., Ma, Y., Tang, C. C., Hellman, M., Feigin, A., Eidelberg, D., & DHAWAN, V. M. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10411-1 · Cited by 20
Blood Vessels as a Key Mediator for Ethanol Toxicity: Implication for Neuronal Damage
Nakayama, K., & Hasegawa, H. (2022) · Life · doi:10.3390/life12111882 · Cited by 20
Imaging of brain barrier inflammation and brain fluid drainage in human neurological diseases
Okar, S. V., Fagiani, F., Absinta, M., & Reich, D. S. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05073-3 · Cited by 20
Cellular junction dynamics and Alzheimer’s disease: a comprehensive review
Asghari, K., Niknam, Z., Mohammadpour-Asl, S., & Chodari, L. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09242-w · Cited by 20
Cerebrovascular Dysfunction in Alzheimer’s Disease and Transgenic Rodent Models
Fang, X., Fan, F., & Roman, R. J. (2024) · Journal of Experimental Neurology · doi:10.33696/neurol.5.087 · Cited by 20
Hossen, F., Sun, G. Y., & Lee, J. C. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.05.044 · Cited by 20
Rather, M. A., Khan, A., Jahan, S., Siddiqui, A. J., & Wang, L. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.05.042 · Cited by 20
Zheng, Y., Cai, X., Wang, D., Chen, X., Wang, T., Xie, Y., Li, H., Wang, T., He, Y., Li, J., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06054-x · Cited by 21
Xiao, H., Yu, X., Yushan, L., Jiang, W., Meng, X., Dong, Z., & Wang, F. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04457-5 · Cited by 20
Joseph, C. R. (2020) · Biomedicines · doi:10.3390/biomedicines8070228 · Cited by 20
Gao, Y., Zhu, J., & Lu, H. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00873-7 · Cited by 20
Glymphatic MRI techniques in sleep and neurodegenerative diseases
Lee, H., Choi, S. H., & Anzai, Y. (2022) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000923 · Cited by 20
Neuroimaging Studies Illustrate the Commonalities Between Ageing and Brain Diseases
Cole, J. H. (2018) · BioEssays · doi:10.1002/bies.201700221 · Cited by 20
Titelbaum, D. S., Engisch, R., Schwartz, E. D., Napoli, S. Q., Sloane, J. A., Samaan, S., Katz, J. B., & Lathi, E. S. (2020) · Journal of Neuroimaging · doi:10.1111/jon.12774 · Cited by 20
Koh, Y., Vázquez‐Rosa, E., Gao, F., Li, H., Chakraborty, S., Tripathi, S. J., Barker, S., Bud, Z., Bangalore, A., Kandjoze, U. P., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2417224122 · Cited by 19
Tanycytic degeneration impairs tau clearance and contributes to Alzheimer’s disease pathology
Sauvé, F., Gomez-Martínez, R., Mbouamboua, Y., Ternier, G., Nampoothiri, S. S., Dupré, E., Garcia, L., Couralet, M., Dewisme, J., Lebouvier, T., et al. (2026) · Cell Press Blue · doi:10.1016/j.cpblue.2026.100003 · Cited by 19
Vikner, T. P., Garpebring, A., Björnfot, C., Nyberg, L. H., Malm, J., Eklund, A., & Wåhlin, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-65944-y · Cited by 19
“Further, Verheggen et al. 13 and van de Haar et al. 14 linked global PS in GM and WM to memory decline over 12 years 13 and found global PS increases in AD patients 14 .”
BackgroundVollhardt, A., Frölich, L., Stockbauer, A., Danek, A., Schmitz, C., & Wahl, A.-S. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106845 · Cited by 19
Verheggen, I. C. M., Freeze, W. M., de Jong, J. J. A., Jansen, J. F. A., Postma, A. A., van Boxtel, M. P. J., Verhey, F. R. J., & Backes, W. H. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.04.025 · Cited by 19
Self-citationStringer, M. S., Heye, A. K., Armitage, P. A., Chappell, F. M., Hernández, M. D. C. V., Makin, S., Sakka, E., Thrippleton, M. J., & Wardlaw, J. M. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102883 · Cited by 19
Colín‐Castelán, D., & Zaina, S. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09486-z · Cited by 19
Cerasuolo, M., Papa, M., Colangelo, A. M., & Rizzo, M. R. (2023) · Biomedicines · doi:10.3390/biomedicines11030861 · Cited by 18
Evidence for interictal blood–brain barrier dysfunction in people with epilepsy
Reiter, J. T., Schulte, F., Bauer, T., David, B., Endler, C., Isaak, A., Schuch, F., Bitzer, F., Witt, J., Hattingen, E., et al. (2024) · Epilepsia · doi:10.1111/epi.17929 · Cited by 18
Chen, G., Li, H., Shao, X., Wang, D. J. J., Hu, W., Han, Y., & Yang, Q. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70089 · Cited by 18
Neuroepigenetic Mechanisms of Action of Ultrashort Peptides in Alzheimer’s Disease
Ilina, A., Khavinson, V., Linkova, N. S., & Petukhov, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084259 · Cited by 18
Lewis, D. G., Zhu, X., Coope, D. J., Zhao, S., King, A. T., Cootes, T. F., Jackson, A., & Li, K. (2022) · Scientific Reports · doi:10.1038/s41598-022-12582-x · Cited by 18
Ye, X., Chen, J., Pan, J., Wu, Q., Wang, Y., Lu, M., Zhang, C., Zhang, Z., Ma, M., Zhu, J., et al. (2022) · Immunological Investigations · doi:10.1080/08820139.2022.2136525 · Cited by 18
“Neuroimaging and immunostaining of human AD brain specimens showed loss of cerebrovascular integrity, impaired BBB structure, abnormal peripheral deposits, and macrophage infiltration (Hultman et al. 2013; Montagne et al. 2017; Sweeney et al. 2018; van de Haar et al. 2016).”
BackgroundPisani, F., Pisani, V., Arcangeli, F., Harding, A., & Singhrao, S. K. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021007 · Cited by 18
Evidence of emerging BBB changes in mid‐age apolipoprotein E epsilon‐4 carriers
Alruwais, N. M., Rusted, J. M., Tabet, N., & Dowell, N. G. (2022) · Brain and Behavior · doi:10.1002/brb3.2806 · Cited by 17
“BBB breakdown is known to lead to AD and has been identified in carriers of the APOEε4 gene with early onset AD (van de Haar et al., 2016, 2017).”
BackgroundExtracellular vesicles contribute to the beneficial effects of exercise training in APP/PS1 mice
Fuller, O. K., McLennan, E. D., Egan, C. L., Perera, N., Terry, L. V., Pyun, J., de Mendonca, M., Telles, G. D., Smeuninx, B., Burrows, E. L., et al. (2025) · iScience · doi:10.1016/j.isci.2025.111752 · Cited by 17
Role of bone marrow-derived macrophages (BMDMs) in neurovascular interactions during stroke
Srivastava, A., Srivastava, P., & Verma, R. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104480 · Cited by 17
Preclinical models of disease and multimorbidity with focus upon cardiovascular disease and dementia
Shabir, O., Moll, T., Matuszyk, M. M., Eyre, B., Dake, M. D., Berwick, J., & Francis, S. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111361 · Cited by 17
Li, Z., Zhao, W., He, B., Koh, T. S., Li, Y., Zeng, Y., Zhang, Z., Zhang, J., & Hou, Z. (2020) · Contrast Media & Molecular Imaging · doi:10.1155/2020/8843084 · Cited by 17
7T dynamic contrast‐enhanced MRI for the detection of subtle blood–brain barrier leakage
Canjels, L. P. W., Jansen, J. F. A., van den Kerkhof, M., Alers, R., Poser, B. A., Wiggins, C. J., Schiffer, V. M. M. M., van de Ven, V. G., Rouhl, R. P. W., Palm, W. M., et al. (2021) · Journal of Neuroimaging · doi:10.1111/jon.12894 · Cited by 17
Self-citationDiabetes Mellitus: A Path to Amnesia, Personality, and Behavior Change
Ahmad, R., Chowdhury, K., Kumar, S., Irfan, M., Reddy, G. S., Akter, F., Jahan, D., & Haque, M. (2022) · Biology · doi:10.3390/biology11030382 · Cited by 17
Effect of antioxidant intake patterns on risks of dementia and cognitive decline
Zhou, F., Xie, X., Zhang, H., & Liu, T. (2022) · European Geriatric Medicine · doi:10.1007/s41999-022-00720-7 · Cited by 17
Lü, Y., Han, W., Luo, Y., Hu, X., Xu, Y. D., Li, H., Hu, C., Huang, D. Y., Ma, J., Yang, Y., et al. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00214 · Cited by 17
Alzheimer's Disease Diagnosis Using Misfolding Proteins in Blood
Lee, H., Ugay, D. A., Hong, S., & Kim, Y. S. (2020) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2020.19.1.1 · Cited by 17
Strategies for blood–brain barrier rejuvenation and repair
Searson, P. C., & Banks, W. A. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01364-5 · Cited by 16
Brain Microvascular Pericyte Pathology Linking Alzheimer's Disease to Diabetes
El‐Ghazawi, K., Eyo, U. B., & Peirce, S. M. (2024) · Microcirculation · doi:10.1111/micc.12877 · Cited by 16
Kouki, M. A., Pritchard, A. B., Alder, J. E., & Crean, S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215103 · Cited by 16
Chen, Y.-C., Lu, B.-Z., Shu, Y., & Sun, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.805637 · Cited by 16
Naganawa, S., Ito, R., Kawamura, M., Taoka, T., Yoshida, T., & Sone, M. (2023) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.mp.2022-0110 · Cited by 16
Acharya, N. K., Grossman, H. C., Clifford, P. M., Levin, E. C., Light, K., Choi, H.-N., Swanson, R. L., Kosciuk, M. C., Venkataraman, V., Libon, D. J., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231028 · Cited by 16
Pardo, A. D., Castaldo, S., Capocci, L., Amico, E., & Maglione, V. (2017) · Journal of Visualized Experiments · doi:10.3791/56389-v · Cited by 16
Kim, S., Moon, G. J., Kim, H. J., Kim, D., Kim, J., Nam, Y., Sharma, C., Leem, E., Lee, S., Kim, K., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15681 · Cited by 16
Musaeus, C. S., Gleerup, H. S., Hasselbalch, S. G., Waldemar, G., & Simonsen, A. H. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230016 · Cited by 15
Lee, K., Yoo, R., Cho, W., Choi, S. H., Lee, S. H., Kim, K. M., Kang, H., & Kim, J. E. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231212173 · Cited by 15
Neurofluid as Assessed by Diffusion-Weighted Imaging
Taoka, T. (2021) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2021.01.002 · Cited by 15
Molecular and histological correlates of cognitive decline across age in male C57BL/6J mice
Britton, R., Liu, A. T., Rege, S. V., Adams, J. M., Akrapongpisak, L., Le, D., Alcantara‐Lee, R., Estrada, R. A., Ray, R. D., Ahadi, S., et al. (2022) · Brain and Behavior · doi:10.1002/brb3.2736 · Cited by 15
“…et al., 2017) and contributing to dementia (Bowman et al., 2007; Janelidze et al., 2017; Montagne et al., 2015; Sweeney et al., 2018; van de Haar et al., 2016), while improving BBB func- tion is associated with beneficial effects (Dempsey et al., 2000; Kamat et al., 2016; Montagne…”
BackgroundEstudillo, E., López-Ornelas, A., Rodríguez-Oviedo, A., Cruz, N. G. D. L., Vargas-Hernández, M. A., & Jiménez, A. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.373672 · Cited by 15
The Lipid Invasion Model: Growing Evidence for This New Explanation of Alzheimer’s Disease
Rudge, J. D. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221175 · Cited by 15
“The BBB leakage in the early AD brain on the left is clearly substantially higher than the leakage in the normal brain on the right [136].”
BackgroundWang, K., Sun, C., Dumčius, P., Zhang, H., Liao, H., Wu, Z., Tian, L., Wang, P., Fu, Y., Wei, J., et al. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00406-6 · Cited by 15
Li, H., Jin, J., Yang, C., Wang, P., Huang, F., Wu, H., Zhang, B., Shi, H., & Wu, X. (2018) · RSC Advances · doi:10.1039/c7ra10246a · Cited by 15
Bae, J., Zhang, J., Wadghiri, Y. Z., Minhas, A. S., Poptani, H., Ge, Y., & Kim, S. (2018) · Magnetic Resonance in Medicine · doi:10.1002/mrm.27145 · Cited by 15
Is the Brain Undernourished in Alzheimer’s Disease?
Aquilani, R., Costa, A. C., Maestri, R., Ramusino, M. C., Perini, G., Boselli, M., Iadarola, P., Buonocore, D., Verri, M., Dossena, M., et al. (2022) · Nutrients · doi:10.3390/nu14091872 · Cited by 15
Photobiomodulation and Other Light Stimulation Procedures
Berman, M. H., Hamblin, M. R., & Chazot, P. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803726-3.00004-3 · Cited by 15
A Review of PARP-1 Inhibitors: Assessing Emerging Prospects and Tailoring Therapeutic Strategies
Ramesh, S., Almeida, S. D., Hammigi, S., Radhakrishna, G. K., Sireesha, G., Theivendren, P., Vellingiri, S., Kunjiappan, S., Ammunje, D. N., & Pavadai, P. (2023) · Drug Research · doi:10.1055/a-2181-0813 · Cited by 14
NX210c drug candidate peptide strengthens mouse and human blood-brain barriers
Greene, C., Rebergue, N., Fewell, G. D., Janigro, D., Godfrin, Y., Campbell, M., & Lemarchant, S. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00577-x · Cited by 14
Lim, C., Lee, H. W., Moon, Y., Han, S., Kim, H. J., Chung, H. W., & Moon, W. (2024) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.29631 · Cited by 14
Cerebrovascular Function in Sporadic and Genetic Cerebral Small Vessel Disease
Stringer, M. S., Blair, G. W., Kopczak, A., Kerkhofs, D., Thrippleton, M. J., Chappell, F. M., Maniega, S. M., Brown, R., Shuler, K., Hamilton, I. F., et al. (2024) · Annals of Neurology · doi:10.1002/ana.27136 · Cited by 14
Self-citationStephenson, A., Mamo, J. C. L., Takechi, R., Hackett, M. J., & Lam, V. (2019) · British Journal Of Nutrition · doi:10.1017/s000711451900268x · Cited by 14
Metadata
- Authors
- van de Haar, H. J., Burgmans, S., Jansen, J. F. A., van Osch, M. J. P., van Buchem, M. A., Muller, M., Hofman, P. A. M., Verhey, F. R. J., & Backes, W. H.
- Affiliations
- Maastricht University Medical Centre (NL)
- Leiden University Medical Center (NL)
- Leiden University (NL)
- ORCID
- Venue
- Radiology
- Published
- 2016-11
- Volume
- 281
- Issue
- 2
- Pages
- 527-535
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2415637550
- Cited by
- 601
- References
- 32
- Citations by year
- 2026: 37 · 2025: 56 · 2024: 66 · 2023: 65 · 2022: 81 · 2021: 89 · 2020: 64 · 2019: 50 · 2018: 42 · 2017: 36 · 2016: 13
- FWCI
- 25.63
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- Radiology (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- Radiological Society of North America
- Internationale Stichting Alzheimer Onderzoek (10553)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- blood-brain barrier disruption, early Alzheimer's disease, dynamic contrast-enhanced MRI, Patlak graphical analysis, plasma volume, gray matter, normal-appearing white matter, deep gray matter, cognitive decline, Mini-Mental State Examination
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Blood Volume, Blood-Brain Barrier, Contrast Media, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Pilot Projects, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.